- Home
- NRDY vs BIOA Comparison
NRDY vs BIOA Comparison
Compare NRDY & BIOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRDY
- BIOA
- Stock Information
- Founded
- NRDY 2007
- BIOA 2015
- Country
- NRDY United States
- BIOA United States
- Employees
- NRDY N/A
- BIOA N/A
- Industry
- NRDY Computer Software: Prepackaged Software
- BIOA Biotechnology: Pharmaceutical Preparations
- Sector
- NRDY Technology
- BIOA Health Care
- Exchange
- NRDY Nasdaq
- BIOA Nasdaq
- Market Cap
- NRDY 155.4M
- BIOA 175.7M
- IPO Year
- NRDY N/A
- BIOA 2024
- Fundamental
- Price
- NRDY $1.25
- BIOA $5.60
- Analyst Decision
- NRDY Hold
- BIOA Hold
- Analyst Count
- NRDY 7
- BIOA 4
- Target Price
- NRDY $1.60
- BIOA $5.67
- AVG Volume (30 Days)
- NRDY 487.2K
- BIOA 190.6K
- Earning Date
- NRDY 11-06-2025
- BIOA 11-06-2025
- Dividend Yield
- NRDY N/A
- BIOA N/A
- EPS Growth
- NRDY N/A
- BIOA N/A
- EPS
- NRDY N/A
- BIOA N/A
- Revenue
- NRDY $178,378,000.00
- BIOA $3,863,000.00
- Revenue This Year
- NRDY $3.34
- BIOA N/A
- Revenue Next Year
- NRDY $10.69
- BIOA N/A
- P/E Ratio
- NRDY N/A
- BIOA N/A
- Revenue Growth
- NRDY N/A
- BIOA N/A
- 52 Week Low
- NRDY $0.75
- BIOA $2.88
- 52 Week High
- NRDY $2.18
- BIOA $26.62
- Technical
- Relative Strength Index (RSI)
- NRDY 38.94
- BIOA 60.70
- Support Level
- NRDY $1.20
- BIOA $5.55
- Resistance Level
- NRDY $1.29
- BIOA $6.00
- Average True Range (ATR)
- NRDY 0.06
- BIOA 0.28
- MACD
- NRDY -0.01
- BIOA 0.01
- Stochastic Oscillator
- NRDY 15.30
- BIOA 63.47
About NRDY Nerdy Inc.
Nerdy Inc is a curated direct-to-consumer platform for live online learning. Its proprietary platform leverages technology, including artificial intelligence ("AI"), to connect students, users, parents, guardians, and purchasers of all ages to tutors, instructors, subject matter experts, educators, and other professionals. The company provides learning experiences across numerous subjects and multiple formats, including one-on-one instruction, small group tutoring, large format classes, tutor chat, essay review, adaptive assessments, and self-study tools. The company generates revenue by selling services to learners and institutions for one-on-one instruction and small group tutoring.
About BIOA BioAge Labs Inc. Common Stock
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare challenges. The pipeline Products of the company are NLRP3 inhibitors, APJ against, and others.